Anna Rudvik
Impact in
-
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Advanced biosensing and bioanalysis techniques
- RNA and protein synthesis mechanisms
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 4
- Lipoproteins and Cardiovascular Health 3
- Coronary Interventions and Diagnostics 1
-
- Heart Failure Treatment and Management 2
- Co-authors
- Anna Collén (2 shared papers)Regina Fritsche‐Danielson (2 shared papers)Kenneth R. Chien (2 shared papers)Li‐Ming Gan (2 shared papers)Rainard Fuhr (1 shared paper)James D. Thompson (1 shared paper)Ligia Chialda (1 shared paper)Michael Kjær (1 shared paper)
- Journals
- Atherosclerosis (2 papers)Journal of the American College of Cardiology (2 papers)Molecular Therapy (1 paper)International Journal of Cardiology (1 paper)Nature Communications (1 paper)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Anna Rudvik
10 papers receiving 303 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 190
- Endocrinology, Diabetes and Metabolism 45
- Cardiology and Cardiovascular Medicine 55
- Rehabilitation 13
- Biomaterials 23
Countries citing papers authored by Anna Rudvik
This map shows the geographic impact of Anna Rudvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rudvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rudvik more than expected).
Fields of papers citing papers by Anna Rudvik
This network shows the impact of papers produced by Anna Rudvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rudvik. The network helps show where Anna Rudvik may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Rudvik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 152 | |
| 2 | 2018 | 58 | |
| 3 | 2022 | 54 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 6 | |
| 8 | 2024 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 1 |
About Anna Rudvik
Anna Rudvik is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology, having authored 10 papers that have together received 311 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (3 papers), Heart Failure Treatment and Management (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Coronary Interventions and Diagnostics (1 paper), Mesenchymal stem cell research (1 paper), Diabetes Management and Research (1 paper), Computational Drug Discovery Methods (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Molecular Biology (190 citations), Endocrinology, Diabetes and Metabolism (45 citations), Cardiology and Cardiovascular Medicine (55 citations), Rehabilitation (13 citations) and Biomaterials (23 citations). Anna Rudvik has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Anna Collén, Regina Fritsche‐Danielson, Kenneth R. Chien, Li‐Ming Gan, Rainard Fuhr, James D. Thompson, Ligia Chialda, Michael Kjær, John L. Joyal and Cecilia Arfvidsson. Their work appears in journals such as Atherosclerosis, Journal of the American College of Cardiology, Molecular Therapy, International Journal of Cardiology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.